GenBody COVID-19 Ag Home Test
Mar 2026
263d
Genbody.Inc. has submitted 1 FDA 510(k) premarket notifications since 2026, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Over-the-counter Covid-19 Antigen Test . Use the specialty filter in the sidebar to narrow results.